Atara brings another experienced investigator onto its off-the-shelf CAR-T quest in latest collaboration
An ambitious Atara has signed up another cancer research center to beef up its pipeline of off-the-shelf CAR-T therapies.
In the new collaboration, the Amgen …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.